Melissa K. Carpenter
Director/Miembro de la Junta en The International Society for Stem Cell Research .
Perfil
Dr. Melissa K.
Carpenter is an Associate at Proteus Venture Partners LLC (Venture Capital).
Dr. Carpenter was previously employed as Vice President-Research & Development by ViaCyte, Inc. She was also employed at CytoTherapuetics, Inc. and served on the board at Geron Corp.
and CyThera, Inc.
Dr. Carpenter received her PhD in Laboratory of Cellular and Molecular Neurobiology from the University of California, Irvine.
Cargos activos de Melissa K. Carpenter
| Empresas | Cargo | Inicio |
|---|---|---|
| The International Society for Stem Cell Research | Director/Miembro de la Junta | 18/03/2021 |
Antiguos cargos conocidos de Melissa K. Carpenter.
| Empresas | Cargo | Fin |
|---|---|---|
Proteus RM LLC (Venture Capital)
 Proteus RM LLC (Venture Capital) Investment ManagersFinance Proteus RM LLC (Venture Capital) (Proteus RM) is a venture capital subsidiary of Proteus RM LLC founded in 2006 by Gregory A. Bonfiglio. The firm is headquartered in Portola Valley, California. | Inversor de Capital Privado | - |
| CytoTherapuetics, Inc. | Corporate Officer/Principal | - |
CyThera, Inc.
 CyThera, Inc. Miscellaneous Commercial ServicesCommercial Services CyThera, Inc. is a biotechnology company focused on developing cell replacement therapies for the treatment of human degenerative disease. The company's technology enables the expansion and proliferation of functional human stem cells in vitro that can be used to restore specialized tissue function. The companyis headquartered in San Diego, CA. | Corporate Officer/Principal | - |
| GERON CORPORATION | Corporate Officer/Principal | - |
ViaCyte, Inc.
 ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Director Técnico/Científico/I+D | - |
Formación de Melissa K. Carpenter.
| University of California, Irvine | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| GERON CORPORATION | Health Technology |
| Empresas privadas | 5 |
|---|---|
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Health Technology |
CyThera, Inc.
CyThera, Inc. Miscellaneous Commercial ServicesCommercial Services CyThera, Inc. is a biotechnology company focused on developing cell replacement therapies for the treatment of human degenerative disease. The company's technology enables the expansion and proliferation of functional human stem cells in vitro that can be used to restore specialized tissue function. The companyis headquartered in San Diego, CA. | Commercial Services |
| CytoTherapuetics, Inc. | Finance |
Proteus RM LLC (Venture Capital)
Proteus RM LLC (Venture Capital) Investment ManagersFinance Proteus RM LLC (Venture Capital) (Proteus RM) is a venture capital subsidiary of Proteus RM LLC founded in 2006 by Gregory A. Bonfiglio. The firm is headquartered in Portola Valley, California. | Finance |
| The International Society for Stem Cell Research |
- Bolsa de valores
- Insiders
- Melissa K. Carpenter
